 Robert Breeze
Concepts (294)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 20 | 2011 | 493 | 1.070 |
Why?
| | Fetal Tissue Transplantation | 15 | 2004 | 35 | 1.040 |
Why?
| | Endolymphatic Hydrops | 2 | 2013 | 3 | 0.850 |
Why?
| | Meniere Disease | 2 | 2013 | 32 | 0.810 |
Why?
| | Trigeminal Neuralgia | 2 | 2019 | 18 | 0.660 |
Why?
| | Surgical Instruments | 3 | 2019 | 51 | 0.660 |
Why?
| | Microvascular Decompression Surgery | 1 | 2019 | 6 | 0.620 |
Why?
| | Polytetrafluoroethylene | 1 | 2019 | 23 | 0.620 |
Why?
| | Intracranial Aneurysm | 5 | 2018 | 97 | 0.500 |
Why?
| | Brain Tissue Transplantation | 8 | 2004 | 19 | 0.470 |
Why?
| | Cell Transplantation | 2 | 2011 | 37 | 0.450 |
Why?
| | Ear, Inner | 1 | 2013 | 49 | 0.410 |
Why?
| | Dopamine | 8 | 2009 | 303 | 0.360 |
Why?
| | Reperfusion Injury | 1 | 2013 | 279 | 0.350 |
Why?
| | Dopaminergic Neurons | 1 | 2011 | 69 | 0.350 |
Why?
| | Meningioma | 2 | 2009 | 91 | 0.340 |
Why?
| | Osteochondroma | 1 | 2009 | 7 | 0.330 |
Why?
| | Dura Mater | 1 | 2009 | 34 | 0.320 |
Why?
| | Meningeal Neoplasms | 2 | 2009 | 100 | 0.320 |
Why?
| | Clinical Trials as Topic | 3 | 2011 | 1050 | 0.280 |
Why?
| | Bone Neoplasms | 1 | 2009 | 247 | 0.270 |
Why?
| | Models, Biological | 1 | 2013 | 1783 | 0.250 |
Why?
| | Mesencephalon | 6 | 2003 | 66 | 0.250 |
Why?
| | Radiosurgery | 3 | 2018 | 344 | 0.240 |
Why?
| | Hemangioma, Cavernous | 2 | 2003 | 15 | 0.240 |
Why?
| | Brain Neoplasms | 5 | 2018 | 1238 | 0.230 |
Why?
| | Craniotomy | 4 | 2019 | 77 | 0.200 |
Why?
| | Mutism | 1 | 2002 | 6 | 0.190 |
Why?
| | Dihydroxyphenylalanine | 4 | 2009 | 9 | 0.190 |
Why?
| | Central Nervous System Neoplasms | 1 | 2003 | 156 | 0.180 |
Why?
| | Brain Stem Neoplasms | 1 | 2002 | 83 | 0.180 |
Why?
| | Cerebral Hemorrhage | 1 | 2002 | 108 | 0.180 |
Why?
| | Nerve Fibers | 1 | 2001 | 96 | 0.180 |
Why?
| | Subarachnoid Hemorrhage | 2 | 2018 | 66 | 0.180 |
Why?
| | Neurons | 4 | 2003 | 1590 | 0.170 |
Why?
| | Humans | 51 | 2019 | 137585 | 0.150 |
Why?
| | Tomography, Emission-Computed | 7 | 2003 | 66 | 0.150 |
Why?
| | Loeys-Dietz Syndrome | 1 | 2018 | 6 | 0.140 |
Why?
| | Carotid Artery Injuries | 1 | 1998 | 41 | 0.140 |
Why?
| | CTLA-4 Antigen | 1 | 2018 | 99 | 0.140 |
Why?
| | Aneurysm, Ruptured | 1 | 2018 | 35 | 0.140 |
Why?
| | Brain | 8 | 2009 | 2668 | 0.130 |
Why?
| | Choroid Plexus Neoplasms | 1 | 1997 | 8 | 0.130 |
Why?
| | Papilloma | 1 | 1997 | 52 | 0.130 |
Why?
| | Middle Aged | 28 | 2017 | 33479 | 0.130 |
Why?
| | Adult | 25 | 2017 | 37929 | 0.130 |
Why?
| | Substantia Nigra | 3 | 2004 | 57 | 0.130 |
Why?
| | Antibodies | 1 | 2018 | 410 | 0.120 |
Why?
| | Antiparkinson Agents | 5 | 2003 | 27 | 0.120 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2018 | 249 | 0.120 |
Why?
| | Intracranial Arteriovenous Malformations | 2 | 2009 | 50 | 0.120 |
Why?
| | Aged | 18 | 2018 | 23961 | 0.120 |
Why?
| | Parietal Bone | 1 | 1995 | 8 | 0.120 |
Why?
| | Quadriplegia | 1 | 1995 | 12 | 0.120 |
Why?
| | Bone Cysts | 1 | 1995 | 9 | 0.120 |
Why?
| | Rhabdomyolysis | 1 | 1995 | 21 | 0.120 |
Why?
| | Epidermal Cyst | 1 | 1995 | 11 | 0.120 |
Why?
| | Head Injuries, Closed | 1 | 1995 | 48 | 0.120 |
Why?
| | Age Factors | 5 | 2013 | 3295 | 0.120 |
Why?
| | Magnetic Resonance Imaging | 10 | 2009 | 3566 | 0.120 |
Why?
| | Levodopa | 3 | 2004 | 30 | 0.110 |
Why?
| | Fibromuscular Dysplasia | 1 | 2014 | 7 | 0.110 |
Why?
| | Wounds, Nonpenetrating | 1 | 1998 | 278 | 0.110 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2014 | 15 | 0.110 |
Why?
| | Double-Blind Method | 9 | 2009 | 1993 | 0.110 |
Why?
| | Male | 30 | 2018 | 67762 | 0.110 |
Why?
| | Brain Diseases | 1 | 1995 | 141 | 0.110 |
Why?
| | Cerebral Arteries | 1 | 2014 | 59 | 0.110 |
Why?
| | Neurofibromatosis 1 | 1 | 2014 | 52 | 0.110 |
Why?
| | Lymphoma | 2 | 2003 | 208 | 0.110 |
Why?
| | Collagen | 1 | 1996 | 452 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2018 | 7635 | 0.110 |
Why?
| | False Negative Reactions | 1 | 2013 | 53 | 0.110 |
Why?
| | Audiometry, Evoked Response | 1 | 2013 | 12 | 0.110 |
Why?
| | Melanoma | 2 | 2018 | 760 | 0.100 |
Why?
| | Autopsy | 1 | 2013 | 95 | 0.100 |
Why?
| | Alleles | 1 | 1996 | 891 | 0.100 |
Why?
| | Temporal Bone | 1 | 2013 | 45 | 0.100 |
Why?
| | Female | 25 | 2018 | 73304 | 0.100 |
Why?
| | Pineal Gland | 2 | 1997 | 16 | 0.100 |
Why?
| | Cerebral Ventricles | 2 | 1991 | 52 | 0.100 |
Why?
| | Pressure | 1 | 2013 | 225 | 0.100 |
Why?
| | Chickenpox | 1 | 2013 | 83 | 0.100 |
Why?
| | Treatment Outcome | 10 | 2018 | 10811 | 0.100 |
Why?
| | Dyskinesias | 2 | 2002 | 19 | 0.100 |
Why?
| | Spinal Cord Injuries | 1 | 1995 | 212 | 0.090 |
Why?
| | Terminology as Topic | 1 | 2013 | 216 | 0.090 |
Why?
| | Intracranial Pressure | 1 | 1991 | 49 | 0.090 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 363 | 0.090 |
Why?
| | Pseudotumor Cerebri | 1 | 1991 | 28 | 0.090 |
Why?
| | Follow-Up Studies | 8 | 2009 | 5131 | 0.090 |
Why?
| | Nerve Tissue | 1 | 1990 | 7 | 0.090 |
Why?
| | Postoperative Complications | 2 | 2002 | 2654 | 0.090 |
Why?
| | Skull Neoplasms | 2 | 2003 | 23 | 0.090 |
Why?
| | Hydrocephalus | 1 | 1991 | 106 | 0.080 |
Why?
| | Embryonic Stem Cells | 1 | 2011 | 129 | 0.080 |
Why?
| | Spinal Cord Diseases | 1 | 1990 | 42 | 0.080 |
Why?
| | Cysts | 1 | 1990 | 113 | 0.080 |
Why?
| | Herpes Zoster | 1 | 2013 | 316 | 0.080 |
Why?
| | Radiopharmaceuticals | 1 | 2009 | 178 | 0.080 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 1081 | 0.080 |
Why?
| | Statistics as Topic | 1 | 2009 | 307 | 0.070 |
Why?
| | Cerebrospinal Fluid | 1 | 1989 | 92 | 0.070 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2009 | 188 | 0.070 |
Why?
| | Point Mutation | 1 | 2009 | 235 | 0.070 |
Why?
| | Microtubule-Associated Proteins | 1 | 2009 | 196 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 1995 | 815 | 0.070 |
Why?
| | Iridium | 1 | 1987 | 7 | 0.070 |
Why?
| | Radioisotopes | 1 | 1987 | 31 | 0.070 |
Why?
| | Pinealoma | 1 | 1987 | 10 | 0.070 |
Why?
| | Encephalitis | 1 | 1989 | 136 | 0.070 |
Why?
| | Fetus | 2 | 1990 | 806 | 0.070 |
Why?
| | Brachytherapy | 1 | 1987 | 121 | 0.060 |
Why?
| | Magnetic Resonance Angiography | 2 | 2018 | 240 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 648 | 0.060 |
Why?
| | Disease Progression | 3 | 2018 | 2757 | 0.060 |
Why?
| | Adolescent | 7 | 2014 | 21513 | 0.060 |
Why?
| | Risk Factors | 2 | 2013 | 10388 | 0.060 |
Why?
| | Dopamine Agents | 1 | 2004 | 19 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2526 | 0.060 |
Why?
| | Transplantation | 1 | 2004 | 34 | 0.050 |
Why?
| | Putamen | 6 | 2003 | 23 | 0.050 |
Why?
| | Incidence | 2 | 2003 | 2804 | 0.050 |
Why?
| | Glioblastoma | 2 | 2003 | 345 | 0.050 |
Why?
| | Endothelial Cells | 1 | 2009 | 785 | 0.050 |
Why?
| | Young Adult | 3 | 2017 | 13209 | 0.050 |
Why?
| | Cerebral Angiography | 3 | 1998 | 109 | 0.050 |
Why?
| | Transplants | 1 | 2003 | 36 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 2031 | 0.050 |
Why?
| | Granuloma, Foreign-Body | 1 | 2003 | 10 | 0.050 |
Why?
| | Transplantation, Heterologous | 1 | 2003 | 194 | 0.050 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 232 | 0.050 |
Why?
| | Glioma | 1 | 1987 | 395 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1164 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2003 | 317 | 0.050 |
Why?
| | Combined Modality Therapy | 4 | 2018 | 1236 | 0.050 |
Why?
| | Reaction Time | 1 | 2004 | 412 | 0.050 |
Why?
| | Parkinsonian Disorders | 1 | 2002 | 35 | 0.050 |
Why?
| | Stem Cell Transplantation | 1 | 2003 | 176 | 0.050 |
Why?
| | Dysarthria | 1 | 2002 | 10 | 0.050 |
Why?
| | Cerebellar Nuclei | 1 | 2002 | 10 | 0.050 |
Why?
| | Laminectomy | 2 | 1999 | 31 | 0.050 |
Why?
| | Confidence Intervals | 1 | 2002 | 329 | 0.050 |
Why?
| | Preoperative Care | 1 | 2004 | 362 | 0.050 |
Why?
| | Globus Pallidus | 1 | 2001 | 26 | 0.050 |
Why?
| | Control Groups | 1 | 2001 | 11 | 0.040 |
Why?
| | Child, Preschool | 2 | 2013 | 11074 | 0.040 |
Why?
| | Cholesterol | 1 | 2003 | 410 | 0.040 |
Why?
| | Thalamus | 1 | 2002 | 107 | 0.040 |
Why?
| | Electric Stimulation Therapy | 1 | 2001 | 81 | 0.040 |
Why?
| | Movement | 3 | 2009 | 278 | 0.040 |
Why?
| | Neural Pathways | 1 | 2002 | 295 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2003 | 614 | 0.040 |
Why?
| | Stereotaxic Techniques | 3 | 1995 | 39 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2009 | 752 | 0.040 |
Why?
| | Placebos | 1 | 2000 | 199 | 0.040 |
Why?
| | Spinal Stenosis | 1 | 1999 | 30 | 0.040 |
Why?
| | Child | 4 | 2018 | 21935 | 0.040 |
Why?
| | Motor Activity | 1 | 2004 | 718 | 0.040 |
Why?
| | Intervertebral Disc Displacement | 1 | 1999 | 40 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2003 | 1738 | 0.040 |
Why?
| | Smooth Muscle Tumor | 1 | 1998 | 6 | 0.040 |
Why?
| | Sarcoma, Synovial | 1 | 1998 | 21 | 0.040 |
Why?
| | Leiomyosarcoma | 1 | 1998 | 28 | 0.040 |
Why?
| | Genotype | 2 | 2009 | 1916 | 0.040 |
Why?
| | Prospective Studies | 2 | 2002 | 7604 | 0.040 |
Why?
| | Dobutamine | 1 | 1998 | 39 | 0.040 |
Why?
| | Aortography | 1 | 1998 | 52 | 0.040 |
Why?
| | Ligation | 1 | 2018 | 92 | 0.040 |
Why?
| | Blood Volume | 1 | 1998 | 61 | 0.030 |
Why?
| | Gene Expression | 1 | 2003 | 1502 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 1999 | 246 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 431 | 0.030 |
Why?
| | Leiomyoma | 1 | 1998 | 77 | 0.030 |
Why?
| | Cell Nucleolus | 1 | 1997 | 17 | 0.030 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 134 | 0.030 |
Why?
| | Inclusion Bodies | 1 | 1997 | 28 | 0.030 |
Why?
| | Drainage | 1 | 2018 | 173 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1996 | 73 | 0.030 |
Why?
| | DNA Probes | 1 | 1996 | 60 | 0.030 |
Why?
| | Animals | 5 | 2011 | 36940 | 0.030 |
Why?
| | Carotid Arteries | 1 | 1998 | 206 | 0.030 |
Why?
| | Postoperative Care | 1 | 2018 | 261 | 0.030 |
Why?
| | Cytoplasm | 1 | 1997 | 274 | 0.030 |
Why?
| | Cerebrovascular Circulation | 1 | 1998 | 243 | 0.030 |
Why?
| | Caudate Nucleus | 4 | 2002 | 23 | 0.030 |
Why?
| | Immobilization | 1 | 1995 | 43 | 0.030 |
Why?
| | Prevalence | 1 | 2002 | 2734 | 0.030 |
Why?
| | Aorta, Thoracic | 1 | 1998 | 267 | 0.030 |
Why?
| | Vision Disorders | 1 | 1997 | 142 | 0.030 |
Why?
| | Micromanipulation | 1 | 1995 | 14 | 0.030 |
Why?
| | Brain Edema | 1 | 1995 | 61 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 3 | 1995 | 2691 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2017 | 658 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2018 | 15657 | 0.030 |
Why?
| | Visual Acuity | 1 | 1997 | 356 | 0.030 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1995 | 173 | 0.030 |
Why?
| | Brain Ischemia | 1 | 1998 | 338 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2001 | 2828 | 0.030 |
Why?
| | Intraoperative Complications | 1 | 1995 | 138 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2000 | 1477 | 0.030 |
Why?
| | Equipment Design | 1 | 1995 | 522 | 0.030 |
Why?
| | Brain Stem | 2 | 1992 | 94 | 0.030 |
Why?
| | Radiography | 1 | 1995 | 822 | 0.030 |
Why?
| | Receptors, Dopamine | 1 | 1993 | 20 | 0.030 |
Why?
| | Nerve Regeneration | 1 | 1993 | 59 | 0.020 |
Why?
| | Fluorine Radioisotopes | 2 | 2002 | 12 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 1998 | 552 | 0.020 |
Why?
| | Neurologic Examination | 4 | 1993 | 110 | 0.020 |
Why?
| | Body Water | 1 | 1991 | 21 | 0.020 |
Why?
| | Acute Disease | 2 | 1998 | 1007 | 0.020 |
Why?
| | Syndrome | 1 | 1991 | 358 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2844 | 0.020 |
Why?
| | Adrenal Glands | 1 | 1990 | 78 | 0.020 |
Why?
| | Neostriatum | 1 | 2009 | 33 | 0.020 |
Why?
| | KRIT1 Protein | 1 | 2009 | 4 | 0.020 |
Why?
| | Corpus Striatum | 1 | 1990 | 167 | 0.020 |
Why?
| | Escherichia coli Infections | 1 | 1989 | 111 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 399 | 0.020 |
Why?
| | Positron-Emission Tomography | 1 | 2009 | 294 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 1988 | 164 | 0.020 |
Why?
| | Gene Frequency | 1 | 2009 | 521 | 0.020 |
Why?
| | Rabbits | 1 | 1989 | 794 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1992 | 2057 | 0.020 |
Why?
| | Time Factors | 4 | 1999 | 6828 | 0.020 |
Why?
| | Pituitary Neoplasms | 1 | 1988 | 190 | 0.020 |
Why?
| | Quality of Life | 1 | 1998 | 2892 | 0.020 |
Why?
| | Sex Factors | 1 | 2009 | 2071 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1988 | 712 | 0.010 |
Why?
| | Trigeminal Nerve | 1 | 1982 | 27 | 0.010 |
Why?
| | Corpus Callosum | 1 | 2003 | 71 | 0.010 |
Why?
| | Temporal Arteries | 1 | 2003 | 45 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 91 | 0.010 |
Why?
| | Treatment Failure | 1 | 2003 | 356 | 0.010 |
Why?
| | Rats | 1 | 1990 | 5647 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2003 | 149 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2004 | 309 | 0.010 |
Why?
| | Culture Techniques | 1 | 2001 | 81 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 767 | 0.010 |
Why?
| | Walking | 2 | 1999 | 529 | 0.010 |
Why?
| | Down-Regulation | 1 | 2003 | 657 | 0.010 |
Why?
| | Work | 1 | 1999 | 18 | 0.010 |
Why?
| | Reoperation | 1 | 1982 | 573 | 0.010 |
Why?
| | Up-Regulation | 1 | 2003 | 843 | 0.010 |
Why?
| | Vascular Surgical Procedures | 1 | 1982 | 303 | 0.010 |
Why?
| | Lumbosacral Region | 1 | 1999 | 58 | 0.010 |
Why?
| | Ethics, Medical | 1 | 2000 | 84 | 0.010 |
Why?
| | Recurrence | 1 | 1982 | 1060 | 0.010 |
Why?
| | Stem Cells | 1 | 2003 | 594 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2003 | 1023 | 0.010 |
Why?
| | Sella Turcica | 1 | 1998 | 18 | 0.010 |
Why?
| | Tumor Virus Infections | 1 | 1998 | 49 | 0.010 |
Why?
| | Low Back Pain | 1 | 1999 | 108 | 0.010 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1998 | 69 | 0.010 |
Why?
| | Fatal Outcome | 1 | 1998 | 303 | 0.010 |
Why?
| | Risk | 1 | 2000 | 912 | 0.010 |
Why?
| | Biomarkers | 1 | 1988 | 4149 | 0.010 |
Why?
| | Herpesvirus 4, Human | 1 | 1998 | 166 | 0.010 |
Why?
| | Pain | 1 | 1982 | 756 | 0.010 |
Why?
| | Herpesviridae Infections | 1 | 1998 | 147 | 0.010 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1998 | 230 | 0.010 |
Why?
| | Spinal Fusion | 1 | 1999 | 251 | 0.010 |
Why?
| | Arteries | 1 | 1997 | 269 | 0.010 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 1995 | 20 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2833 | 0.010 |
Why?
| | Muscle Contraction | 1 | 1998 | 424 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1995 | 224 | 0.010 |
Why?
| | Vasodilation | 1 | 1998 | 499 | 0.010 |
Why?
| | RNA, Viral | 1 | 1998 | 656 | 0.010 |
Why?
| | Primates | 1 | 1995 | 126 | 0.010 |
Why?
| | Prednisone | 1 | 1995 | 240 | 0.010 |
Why?
| | Length of Stay | 1 | 1999 | 1215 | 0.010 |
Why?
| | Cyclosporine | 1 | 1995 | 268 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 1995 | 416 | 0.010 |
Why?
| | Antibody Formation | 1 | 1995 | 298 | 0.010 |
Why?
| | Tissue Survival | 1 | 1992 | 18 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 1995 | 268 | 0.010 |
Why?
| | Dominance, Cerebral | 1 | 1993 | 54 | 0.010 |
Why?
| | Spleen | 1 | 1995 | 514 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 1997 | 1946 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1995 | 491 | 0.010 |
Why?
| | Cohort Studies | 1 | 2002 | 5742 | 0.010 |
Why?
| | Video Recording | 1 | 1992 | 180 | 0.010 |
Why?
| | Spinal Cord | 1 | 1992 | 370 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1990 | 180 | 0.010 |
Why?
| | Activities of Daily Living | 1 | 1992 | 413 | 0.000 |
Why?
| | Cell Line | 1 | 1995 | 2847 | 0.000 |
Why?
| | Motor Skills | 1 | 1990 | 97 | 0.000 |
Why?
| | Antigens, Nuclear | 1 | 1988 | 18 | 0.000 |
Why?
| | Aneuploidy | 1 | 1988 | 89 | 0.000 |
Why?
| | Pituitary Gland | 1 | 1988 | 148 | 0.000 |
Why?
| | Fluorescent Antibody Technique | 1 | 1988 | 390 | 0.000 |
Why?
| | Cell Cycle | 1 | 1988 | 601 | 0.000 |
Why?
| | Flow Cytometry | 1 | 1988 | 1178 | 0.000 |
Why?
|
|
Breeze's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|